Catalyst Pharmaceutical (CPRX)

Add to Watchlists
Create an Alert
2.85 -0.03  -0.87% NASDAQ Dec 18, 5:00PM BATS Real time Currency in USD

Catalyst Pharmaceutical Research and Development Expense (Quarterly):

2.886M for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

Catalyst Pharmaceutical Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Catalyst Pharmaceutical Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2004. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 2.886M
June 30, 2014 2.099M
March 31, 2014 2.749M
Dec. 31, 2013 2.068M
Sept. 30, 2013 2.804M
June 30, 2013 2.132M
March 31, 2013 1.092M
Dec. 31, 2012 0.7447M
Sept. 30, 2012 0.6548M
June 30, 2012 0.5327M
March 31, 2012 0.7273M
Dec. 31, 2011 0.9602M
Sept. 30, 2011 0.6141M
June 30, 2011 0.9056M
March 31, 2011 0.904M
Dec. 31, 2010 0.5692M
Sept. 30, 2010 0.5001M
   
June 30, 2010 0.7979M
March 31, 2010 0.4396M
Dec. 31, 2009 0.5476M
Sept. 30, 2009 0.851M
June 30, 2009 1.238M
March 31, 2009 2.461M
Dec. 31, 2008 3.272M
Sept. 30, 2008 2.452M
June 30, 2008 1.902M
March 31, 2008 1.084M
Dec. 31, 2007 0.722M
Sept. 30, 2007 0.5033M
June 30, 2007 1.003M
March 31, 2007 0.7625M
Dec. 31, 2006 0.3209M
Sept. 30, 2006 0.2355M
June 30, 2006 0.2701M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

CPRX Research and Development Expense (Quarterly) Benchmarks

Companies
Salix Pharmaceuticals 50.84M
Mallinckrodt 43.80M
Biomarin Pharmaceutical 125.69M

CPRX Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 0.4396M Mar 2010
Maximum 2.886M Sep 2014
Average 1.236M

CPRX Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("CPRX", "r_and_d_expense")
  • Last 5 data points: =YCS("CPRX", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.